Videos

Innovation promises new ways to deliver medication. One example is genetically targeted technologies.

As rates of heart attack and stroke soar, now is the time for policymakers to ensure that heart patients get the right medicine at the right time.

Alternative funding programs come at a significant cost to patients and the health care system.

Darin Burnham had a heart attack and was denied his doctor-prescribed medication to manage his condition. Hear his story.

Latrice Baxter went in for routine heart screens and several hours later found herself on the operating table. Hear her story.

A special message from Former U.S. Surgeon General Jerome Adams on the state of hypertension in America.

Hypertension is a common condition. But when it comes to managing it, each patients’ struggle can be different.

Speakers:

U.S. Representative Joyce Beatty (OH-3)

Pamela Garmon Johnson, National Vice-President of Health Equity and Partnerships and National Executive Director for the National Hypertension Control Initiative, American Heart Association

Barbara Hutchinson, MD, PhD, Chesapeake Cardiac Care

The burden of hypertension falls disproportionately on communities of color. Now is the time to make hypertension history.

It’s time for innovation, access and awareness. Together, we can make hypertension history.

Hypertrophic cardiomyopathy, or HCM, is a genetic disorder that occurs when the heart muscle thickens, making it harder to pump blood.

Anahita Dua, MD, explains that symptomless PAD can be a silent killer. That’s why screening, testing and education are critical for patients.